- --------------------------------------------------------------------------------

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D. C. 20549

                                    FORM 10-K

                  [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR
                  15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
                     For the fiscal year ended June 30, 1998

                                       Or

                 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR
                  15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
                  For the transition period from______to______

                           Commission File No. 2-75313

                              PROCARE AMERICA, INC.
                              ---------------------
                 (FORMERLY KNOWN AS ROYAL EQUITY EXCHANGE, INC.)
             (Exact name of registrant as specified in its charter)

                   NEVADA                                        84-0871427
                   ------                                        ----------
          (State or Other Jurisdiction                        (I.R.S. Employer)
         Incorporation or Organization)                      Identification No.)

         12995 SO. CLEVELAND AVENUE, SUITE 109, FT MYERS, FL       33907
         (Address of Principal Executive Offices)                (Zip Code)

       Registrant's telephone number, including area code: (941) 418.0021

           SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:
                                      NONE

          SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT;
                 TITLE OF CLASS    COMMON STOCK $0.001 PAR VALUE

         Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes [ ] No [X]

         Indicate by check mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-K is not contained herein, and will not be contained,
to the best of Registrants knowledge, in a definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. [X]

         The aggregate market value of the voting stock held by non-affiliates
as of June 30, 1998 was approximately $2,977,468.

         There were 7,291,757 shares of the Registrants common stock outstanding
as of June 30, 1998.

- --------------------------------------------------------------------------------



INCORPORATION BY REFERENCE

         Specified portions of the registrant's Form 8-K filed May 8, 1997 are
incorporated by reference in Part III hereof.

FORWARD LOOKING STATEMENTS OR INFORMATION

         Certain statements, other than statements of historical fact, included
in this Annual Report, including, without limitation, the statements under
"Business" and "Management's Discussion and Analysis of Financial Condition and
Results of Operations" are, or may be deemed to be, forward-looking statements
that involve significant risks and uncertainties, and accordingly, there is no
assurance that these expectations will be correct. These expectations are based
upon many assumptions that the registrant believes to be reasonable, but such
assumptions ultimately may prove to be materially inaccurate or incomplete, in
whole or in part and, therefore, undue reliance should not be placed on them.
Several factors which could cause actual results to differ materially from those
discussed in such forward-looking statements include, but are not limited to:
pricing policies of competitors, the ability to attract and retain employees in
key positions and uncertainties and changes in general economic conditions. All
subsequent forward-looking statements attributable to the registrant or persons
acting on its behalf are expressly qualified in their entirety.

                                     PART I

ITEM 1. BUSINESS

         The Company is a development stage business that is focused on
providing certain medical services, primarily that of a "home health agency"
through its wholly owned operating subsidiary ProCare Home Health, Inc. The
Company provides nursing and assisted nursing services to individual patients in
their homes, and/or nursing and assisted nursing services and staffing by
contractual arrangement with local nursing homes, assisted living facilities and
hospitals. The Company is licensed to provide these services by the Agency for
Health Care Administration, State of Florida. The Company provides these
services on a completely private basis.

ENVIRONMENTAL MATTERS

         The Company, when operational, is subject to various federal, state and
local regulations concerning the environment and hazardous waste disposal.
Efforts to maintain compliance with such regulations have not required
expenditures material to the Company's overall operating performance or
financial condition.

EMPLOYEES

         As of June 30, 1998, the Company and its wholly owned subsidiary
ProCare Home Health, Inc. had six wage or salaried employees.

ITEM 2. PROPERTIES

         In May 1997 the Company entered into a three-year lease agreement for
office space at 12995 South Cleveland Avenue, Suite 109, Ft. Myers, Florida,
33907, which serves as the Company's principal operational and executive office.

ITEM 3. LEGAL PROCEEDINGS

         In January 1998 the Company was sued by the former President and his
spouse for compensation allegedly due them for services they rendered to the
Company. The Company, in its answer to these claims, rejected the claims and
countered-sued for damages for alleged breach of fiduciary duties. The
litigation was settled by the parties under an agreement that allowed the
Company to buy back, at its option, certain shares owned by the former President
and his spouse. To date the Company has purchased 125,000 shares for a sum of
$25,000. There are no other legal proceedings pending or to the knowledge of the
Company threatened, that, if determined adversely to the Company would have a
material adverse effect on the Company.


                                       2



ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

         The Company submitted no matters for security holder voting during the
fiscal year ending June 30, 1998.

                                     PART II

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

         The Company's common stock (symbol: REEX) was listed on the
Over-the-Counter (OTC) Bulletin Board. In March of 2000 the Company was
de-listed for non-compliance with SEC filing requirements. The shares are now
listed on the "pink sheets" as published by the National Quotation Bureau.

         The Company's common stock is not listed on any national stock exchange
or on NASDAQ. The OTC Bulletin Board is a regulated quotation service that
displays real-time quotes, last-sale prices and volume information for
non-listed (over-the-counter) equity securities. The OTC Bulletin Board is a
reporting system for participating market makers, not an issuer listing service,
and should not be confused with the NASDAQ Stock Market. Participating market
makers in the bulletin board system enter quotes and trade reports on a closed
computer network and the information is made publicly available through numerous
websites and other locations. The OTC Bulletin Board is distinct from the "pink
sheets" published by the National Quotation Bureau which also report on
transactions in non-listed equity securities.

Stockholders of record at June 30, 1998 numbered approximately 813. The Company
has not paid cash dividends on its Common Stock in the past and currently plans
to retain earnings, if any, for business development and expansion.

                             QUARTERLY STOCK PRICES

                                                 FIRST   SECOND  THIRD   FOURTH
                                                 ------------------------------

Closing Stock Price end of each quarter........  $1.56   $0.69   $1.03   $0.88

ITEM 6. SELECTED FINANCIAL DATA

         The following table depicts selected consolidated financial data for
the two-year period ended June 30, 1998 as derived from the consolidated
financial statements of the Company. This table should be read in conjunction
with "Management's Discussion and Analysis of Financial Condition and Results of
Operations" and the Company's audited consolidated financial statements and
notes thereto appearing elsewhere herein.

                                                               AS OF
                                                    ---------------------------
CONSOLIDATED BALANCE SHEET DATA                       6/30/98         6/30/97
                                                      -------         -------

Working capital deficit..........................   $ (330,913)     $ (272,352)
Total assets.....................................       17,241          27,640
Long-term debt, including current portion........      225,028         178,820
Stockholders' equity (deficit)...................     (323,723)       (260,784)

                                                             YEAR ENDED
                                                    ---------------------------
CONSOLIDATED STATEMENT OF OPERATIONS DATA             6/30/98         6/30/97
                                                      -------         -------

Net patient services revenue....................    $      -0-      $   11,891
Other...........................................           200             -0-
Operating Expenses:
     Bad debt expense...........................           -0-          33,963
     Medical supplies...........................           -0-          13,685
     General and administrative.................        94,924         236,896
     Payroll....................................       145,401             -0-
     Consulting fees paid to directors
       and stockholders.........................       266,363          42,730
     Interest expense...........................        28,375          14,964
     Loss on disposal/abandonment of
       Fixed assets.............................           -0-          43,445
                                                    ----------      ----------
                                                    $  535,063      $  385,683
                                                    ----------      ----------

Net Loss                                            $ (534,863)     $ (373,792)
                                                    ==========      ==========

Net loss per common share.......................    $     (.11)     $     (.08)
                                                    ==========      ==========
Weighted average number of
   Common shares outstanding....................     5,058,839       4,735,400
                                                    ==========      ==========


                                       3



ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS

HISTORICAL EVENTS

Reverse Split of Common Stock; Surrender of Control Shares; Merger
- ------------------------------------------------------------------

         On December 29, 1995, the Company declared a 40 for 1 reverse split of
the Company's outstanding common stock whereby 1,449,779 shares of common stock
were issued in exchange for 57,991,165 shares of common stock outstanding.
Before and after the exchange, the Company had 500,000,000 authorized shares of
common stock (NOTE: other documents of the Company reflect that this stock split
occurred on March 15, 1996). Subsequent to this stock split, the then control
shareholder of the Company, Robert Slominski, surrendered 900,000 shares of the
Company, leaving 549,779 shares of the Company outstanding.

         In June 1996 the Company entered into a merger transaction whereby all
of the shares of ProCare America, Inc. were acquired by the Company in exchange
for 3,888,984 shares of the Company (NOTE: other documents of the Company
provided by the previous audit firm reflect the merger as occurring February 7,
1996 with the number of shares in the transaction being 4,056,484).
Approximately 1,300,000 of these shares were issued to Owen L. Stephens who
became Chairman of the Board of Directors, President and Chief Executive Officer
of the Company. Subsequently, Mr. Stephens resigned these positions as discussed
below.

         As of May 8, 1997, the Company had issued and outstanding 5,692,913
shares of common stock.

Resignation of Board Members and Election of New Board Members and Officers;
- ----------------------------------------------------------------------------
Resignation of Bookkeeper
- -------------------------

         Certain of the shareholders of the Company were not satisfied with the
performance of the Company and sought a change in the Company's board of
directors and management. Responding to pressures from these Company
shareholders, Owen L. Stephens, by letter dated January 29, 1997, tendered his
resignation as a director of the Company, Chairman of the Board, President and
Chief Executive Officer of the Company and all positions with subsidiaries of
the Company; by letter dated January 29, 1997, Maryann Stephens tendered her
resignation as an officer and director of the Company and all positions with
subsidiaries of the Company; and, by letter dated January 30, 1997, Donna Kay
tendered her resignation as a director of the Company and all positions with
subsidiaries of the Company. At a special meeting of the board of directors held
on February 11, 1997, the sole remaining director, William Strahan, accepted the
foregoing resignations. The foregoing former directors, Mr. Stephens, Mrs.
Stephens and Mrs. Kay, have not expressed to the Company, and have not furnished
the Company with a letter describing, any disagreement they may have had with
the Company's operations, policies or practices.

         At the February 11, 1997 board meeting, the sole remaining director,
William Strahan, elected Donald Strong to fill the board vacancy created by the
resignation of Owen Stephens, James Karabasz to fill the board vacancy created
by the resignation of Maryann Stephens and Fred Hodgdon to fill the board
vacancy created by the resignation of Donna Kay. Following their election, the
newly constituted board of directors elected Mr. Strahan as Chairman of the
Board, Donald Strong as President and Secretary and James Karabasz as Treasurer.

         By letter dated February 14, 1997, Richard E. Shield, P.A. a certified
public accountant, stated that he thought because of non-payment of his fees it
was prudent to terminate his present engagement with the Company in light of the
changes in the Company's organization and management. Mr. Shield prepared the
Company's payroll tax returns and W-2's and, according to Mr. Shield's letter,
provided other consultation and accounting services to the Company. In his
letter to the Company, Mr. Shield indicated his willingness on being brought
current on his fee payments to be re-engaged by the Company. Mr. Shield was not
engaged as the Company's principal accountant to audit the Company's financial
statement. The Company's principal accountant was Stirtz, Bernards & Company.
Effective February 4, 1998 the Company entered into a letter of engagement with
Wentzel, Berry & Alvarez P. A. (now known as Wentzel, Berry, Wentzel & Phillips,
P. A.) as the principal audit firm. This action was ratified by the shareholders
on September 16, 1998.


                                       4



Failure to File Periodic Reports and Provide Audited Financials; Absence of
- ---------------------------------------------------------------------------
Current Information
- -------------------

         Based upon information recently learned by the Company's new directors
and officers, it appears that the prior management of the Company did not file
the periodic reports as required under the Securities Exchange Act of 1934 and
the rules and regulations promulgated thereunder since November 13, 1991, when
the Company filed the Form 8-K, Current Report, discussed above.

         The newly constituted board of directors believes that prior management
did not provide the new board with full and current information on the
operations and financial condition of the Company. The board of directors has
acted to seek and obtain updated and complete information on the Company. In the
spring of 1997 representatives of the Company discussed the situation with its
then principal accounting firm, Stirtz, Bernards & Company.

Retention of Management Organization
- ------------------------------------

         At its meeting of February 19, 1997, the board authorized the retention
of a medical management service to manage the day to day affairs of the Company,
under the supervision of the board of directors, pursuant to the terms of an
engagement letter which sets forth the duties to be performed. The long-term
goals to be accomplished by the medical management service were to organize the
books and records of the Company, assist the Company in its fund-raising
efforts, retain competent personnel to provide medical services to patients of
the Company, advise the Company on recommended actions to return the Company to
a fully operational status and explore possible acquirors for the Company should
this be in the best interest of the shareholders. These goals were progressive
and their accomplishment was dependent upon the Company obtaining an adequate
source and level of funding in the immediate future.

         The principals of this management entity were Brent Peterson, who
previously served for a short period of time as an officer and director of one
of the Company's subsidiaries, and Paul Schryver. While the principals of the
management entity were experienced businessmen, they had not previously provided
management services to a medical provider.

         For services rendered in the past and to be rendered in the future, the
principals of the management entity were to be compensated at the rate of $100
per hour plus approved out of pocket expenses and the board granted to each of
the two principals of the management entity warrants, as of February 24, 1997,
for 400,000 shares of common stock of the Company (for a total of 800,000
shares) as follows: 150,000 shares could be purchased within one year at $0.25
per share, 150,000 shares could be purchased from months 12 to 24 at $0.50 per
share and 100,000 shares could be purchased from months 24 to 36 at $0.75 per
share.

Authorization to Borrow Funds with Convertible Features
- -------------------------------------------------------

The management service retained by the Company to manage the Company's day to
day operations has advised the board that significant funds would be required by
the Company to return it to full operational status. Specifically, the
management service has estimated that, until accounts receivable begin to flow
into the Company, the Company's short term cash needs are approximately $90,000
and, to bring the Company to fully operational status, approximately $500,000 in
cash would be required. After consideration of this recommendation, the board
determined, at its meeting held on February 11, 1997, that the Company should
seek to borrow $750,000 in short term loans thereby providing a cushion of
approximately $160,000 beyond the amount recommended by the management service,
assuming funds can be raised. Accordingly, at this meeting, the board authorized
the Company to borrow up to $750,000 from investors for a term of one year at an
interest rate of 10 % per annum. At the option of the investor, the loans may be
converted into common stock of the Company at the conversion rate of $0.50 per
share, exercisable prior to the loan maturity date. Further, each loan carries
warrants entitling the lender to purchase, within one year after the loan is
advanced, a number of shares of common stock equal to the original principal
amount of the loan at a warrant price of $0.75 per share and, from months 12 to
24, a number of shares of common stock equal to the original principal amount of
the loan at a warrant price of $1.00 per share. The proceeds of these loans will
be used to pay accounts payable that are now due and any remaining loan proceeds
will be used to fund the Company's operations. There can be no assurance that
the Company's efforts to raise funds will be successful or, if successful, that
the Company will return to a fully operational status or that these activities
will be successful or profitable. For the fiscal year ending June 30, 1998 the
Company has raised $157,000 and a cumulative amount of $207,000 since approval
of this program on February 11, 1997 in the form of loans from private investors
subject to the terms and conditions described above. These funds have been used
to pay accounts payable deemed to be a priority by the Board of Directors.


                                       5



RESULTS OF OPERATIONS
Operating Income
- ----------------

         For the year ended June 30, 1998 there was no net patient services
revenue. The only revenue generated totaled $200.00. The Company did not resume
revenue generating operations until June of 1998.

Current Operations
- ------------------

         For the first four months of the fiscal year the medical management
service retained by the Company continued to determine the assets and
liabilities of the Company, organizing the books and records, assisting in
fund-raising and development of a reorganizational plan to return the Company to
operational status as a licensed medical services provider. The medical
management service had advised the Board of Directors that a minimum of $600,000
in cash would be required to adequately address the past obligations and provide
working capital for initiating medical services operations. Approximately
$100,000 would be allocated to past obligations and $500,000 would be necessary
to implement the medical services operation. The Board of Directors has approved
the issuance $750,000 in short term loans (see Authorization to Borrow Funds
with Convertible Feature above). In October James Karabasz resigned from the
Board of Directors because he was unable to devote sufficient time to the
Company as it moved toward operating status. Brent Peterson, Thomas Unsworth,
and Joseph Ellis were appointed by the remaining Board members to the Board of
Directors to fill vacancies on the Board. The operational officers of the
Company were appointed by the Board as follows: Brent Peterson, Chairman/CEO;
Donald Strong, President/COO; Thomas Unsworth, Vice-President/Treasurer; Joseph
Ellis, Vice-President/Secretary. The agreement with the medical management
services company was terminated. The Board reviewed a proposal by Maryann
Stephens, shareholder and former nurse/medical director of the Company's
subsidiary Caring Health. After a trial period it was determined by management
that the parties to the proposal had a conflict of interest and the proposal was
rejected. In December management engaged a healthcare professional to
restructure and restart operational services. It was at this juncture that
management learned that the Company's license had been terminated by the State
of Florida for a non-compliance issue under the previous management. The process
to re-license is a long, detailed procedure and requires the development of
systems, hiring of staff and passing an Agency for Healthcare Administration
audit. The Company administratively dissolved its subsidiary corporations Caring
Health Support Professionals, Inc. and Caring, Inc. The Company changed the name
of its subsidiary ProCare America, Inc., incorporated in Minnesota to ProCare
Pharmacies of America, Inc. The Company then incorporated ProCare Home Health,
Inc. to be its wholly owned operating entity. All of these changes were
initiated and completed to establish a fresh base on which to re-commence
operations. Starting in December the Company focused on restructuring and
rebuilding the systems to qualify for licensing with the State of Florida. In
late March the Company was audited by the State of Florida and approved for
license. On May 20, 1998 the Company was licensed to provide medical services to
patients. The first contracts and patients treated were in June 1998. To support
this development stage the Company, from February 11, 1997 to June 30, 1998,
raised $207,000 cash from the sale of short term notes to private investors as
approved by the Board and $100,000 in cash and deferred debt as long term debt
from Brent Peterson, a shareholder and member of the medical management service
retained by the Company.

Accounts Payable and Receivable: Assets of the Company
- ------------------------------------------------------

         As of June 30, 1998, the Company had accounts payable of $57,594, notes
payable to others of $142,208, bank notes of $82,820, accrued payroll taxes of
$38,138 and accrued interest of $20,204. As of June 30, 1998 total accruals and
notes payable totaled $340,964. Cash as of June 30, 1998 was $8,491 and total
assets of the company were $17,241.

Overview and Outlook for 1999
- -----------------------------

         During the last seven months of the Company's fiscal year, management
has focused on organizing the restructuring to allow the Company to return to
medical service operations. The pace of restructuring has been slowed by the
difficulty in securing sufficient working capital on a timely basis to meet the
operational requirements for re-licensing and to restore the Company to full
operational status In fiscal 1999 there will be continued focus on raising the
required capital. As part of its plan management intends to carefully evaluate
its medical services model and target those areas that appear to provide the
most efficiencies and profit performance. Management expects to continuously
monitor and review all operations with a view to improve financial returns.


                                       6



ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAL DATA

         The following consolidated financial statements of the Company and its
Independent Accountants' Opinion are set forth in Part IV, Item 14, of this
Report:

         (i)      Consolidated Balance Sheets-as of June 30, 1999 and June 1998.

         (ii)     Consolidated Statements of Operations, Cash Flows and
                  Shareholders' Equity (Deficit) for the year's ended June 30,
                  1999 and June 30, 1998.

         (iii)    Notes to the Consolidated Financial Statements; and
                  Unqualified Opinion of Independent Accountants dated April 27,
                  2001, except for Note 13, as to which date is December 12,
                  2001.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH AUDITORS ON ACCOUNTING AND FINANCIAL
DISCLOSURES

         Effective February 4, 1998 the Company terminated its relationship with
Stirtz, Bernards & Company and entered into a letter of engagement with Wentzel,
Berry & Alvarez P. A.(now known as Wentzel, Berry, Wentzel & Phillips P. A.) as
its principal audit firm. There have been no disagreements between management
and the previous and current accounting firms as regards any accounting issues
or financial disclosure matters.

                                    PART III

ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT

         Brent Peterson                 Chairman of the Board/CEO/Director

         Donald Strong                  President/COO/Director

         Thomas Unsworth                Vice-President/Treasurer/Director

         Joseph Ellis                   Vice-President/Secretary/Director

         Richard Mohring Sr.            Director

         William Strahan                Director

ITEM 11. EXECUTIVE COMPENSATION

         The board had authorized the retention of a medical management service
to manage the day-to-day affairs of the Company and the information appearing in
the Company's Form 8-K filed May 8, 1997 under the caption "Retention of
Management Organization" is incorporated herein by reference. That agreement was
terminated in October 1997.

         Current Officers                         Annual Compensation
         ----------------                         -------------------

         Brent Peterson - Chairman/CEO               $84,000.00 (1)
         Donald Strong - President/COO               $60,000.00

(1)      Does not include reimbursement for health insurance premiums.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

                                      Number of Shares             Percent
Name of Beneficial Owner              Beneficially Owned (1)       of Total (2)
- ------------------------              ----------------------       ------------
Courtney Hansen.....................           250,000                 3.57%
Frans Hansen........................            50,000                 0.71%
Gerald Hansen.......................           141,656                 2.03%
Jordyn Hansen.......................           250,000                 3.57%
David Perrigo.......................            70,000                 1.00%
Penny (Perrigo) Stoltz..............            70,000                 1.00%
Robert Perrigo......................            70,000                 1.00%
William Perrigo Jr..................            70,000                 1.00%
William Perrigo Sr..................            52,000                 0.74%
William Sr. & David Perrigo TTEE....           480,000                 6.86%
Richard Prescott....................           500,000                 7.15%
Mary Joy Stead......................           412,350                 5.90%
Owen & Maryann Stephens.............         1,175,000                16.80%
     All beneficial owners
     As a group.....................         3,591,006                51.35%


                                        7



(1)      Except as other wise indicated, the persons named in the table have
         sole voting and investment power with respect to all shares shown as
         beneficially owned by them. The information shown above is based upon
         information furnished to the company by the named persons. Information
         relating to beneficial ownership of shares is based upon "beneficial
         ownership" concepts set forth in the rules promulgated by the
         Securities Exchange Act of 1934, as amended. Under such rules a person
         is deemed to be a "beneficial owner" of a security if that person has
         or shares "voting power" which includes the power to vote or to direct
         the voting of such security, or "investment power", which includes the
         power to dispose or to direct the disposition of such security. A
         person is also deemed to be a beneficial owner of any security of which
         that person has the right to acquire beneficial ownership within 60
         days. Under the rules, more than one person may be determined to be a
         beneficial owner of the same securities.
(2)      In calculating the percentage ownership for a given individual or
         group, the number of shares of the company's common stock outstanding
         includes unissued shares subject to options, warrants, rights or
         conversion privileges exercisable within 60 days by such individual or
         group, but unissued shares are not deemed outstanding in calculating
         the percentage ownership for other persons or groups.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

         The information appearing in the Company's Form 8-K filed May 8, 1997
under the caption "Granting of Options" is incorporated herein by reference.

                                     PART IV

ITEM 14. EXHIBITS, FINANCIAL STATEMENTS AND REPORTS ON FORM 8-K

         (a) (1) Financial Statements.

CONSOLIDATED FINANCIAL STATEMENTS

         The following consolidated financial statements of ProCare America,
         Inc. (formerly known as Royal Equity Exchange, Inc. and subsidiaries
         and Report of Independent Accountants are attached as pages F1 through
         F26 to this report:

                  (i)      Independent Auditors' Report dated April 27, 2001,
                           except for Note 13, as to which date is December 12,
                           2001.

                  (ii)     Consolidated Balance Sheets for the years ended June
                           30, 1999 and June 30, 1998 and the period from
                           September 22, 1993 (inception) to June 30, 1999;

                  (iii)    Consolidated Statements of Operations for the years
                           ended June 30, 1999, and June 30, 1998 and the period
                           from September 22, 1993 (inception) to June 30, 1999;

                  (iv)     Consolidated Statements of Stockholders Equity
                           (Deficit) for the years ended June 30, 1999, and June
                           30, 1998 and the period from September 22, 1993
                           (inception) to June 30, 1999;

                  (v)      Consolidated Statements of Cash Flows for the years
                           ended June 30, 1999, and June 30, 1998 and the period
                           from September 22, 1993 (inception) to June 30, 1999;

                  (vi)     Notes to the Consolidated Financial Statements.

         (b) Reports on Form 8-K:


                                       8



                                   SIGNATURES

     Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.

                                 Pro Care America, Inc.
                                 (formerly known as Royal Equity Exchange, Inc.)
                                 (Registrant)

                                 By   /s/Brent Peterson
                                    -----------------------------------
                                    Chairman of the Board/CEO, Director
                                       Date: June 30, 1998

     Pursuant to the requirements of the Securities Exchange Act of 1934, this
report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.

             Signature                          Title                  Date

By       /s/Brent Peterson            Chairman of the Board/CEO    June 30, 1998
   -------------------------------            Director
         Brent Peterson

By:      /s/Donald Strong             President/COO/Director       June 30, 1998
   -------------------------------
         Donald Strong

By:      /s/Thomas Unsworth           Vice-President/Treasurer     June 30, 1998
   -------------------------------           Director
         Thomas Unsworth

By:      /s/Joseph Ellis              Vice-President/Secretary     June 30, 1998
   -------------------------------           Director
         Joseph Ellis

By:      /s/Richard Mohring Sr.       Director                     June 30, 1998
   -------------------------------
         Richard Mohring, Sr.

By:      /s/William Strahan           Director                     June 30, 1998
   -------------------------------
         William Strahan


                                       9